>>> US Research Calls I

Research Calls I
  • Upgrades:
    • Accenture (ACN) upgraded to Buy from Hold at TD Cowen; tgt raised to $400
    • Amerant Bancorp (AMTB) upgraded to Overweight from Neutral at Piper Sandler; tgt raised to $26.50
    • BlackLine (BL) upgraded to Overweight from Equal-Weight at Morgan Stanley; tgt raised to $70
    • Brookfield Renewable Partners (BEP) upgraded to Buy from Neutral at UBS; tgt raised to $31
    • Brown-Forman (BF.B) upgraded to Overweight from Equal Weight at Barclays; tgt raised to $53
    • Cadence Bank (CADE) upgraded to Overweight from Equal-Weight at Morgan Stanley; tgt raised to $39
    • Frontier Group Holdings (ULCC) upgraded to Mkt Perform from Underperform at Raymond James
    • Hess (HES) upgraded to Outperform from Peer Perform at Wolfe Research; tgt $150
    • U.S. Bancorp (USB) upgraded to Overweight from Equal-Weight at Morgan Stanley; tgt raised to $57
    • Walt Disney (DIS) upgraded to Buy from Neutral at Seaport Research Partners; tgt $108
    • Westlake Corporation (WLK) upgraded to Overweight from Equal Weight at Barclays; tgt raised to $180
    • Zions Bancorp (ZION) upgraded to Equal-Weight from Underweight at Morgan Stanley; tgt $54
  • Downgrades:
    • Bruker (BRKR) downgraded to Peer Perform from Outperform at Wolfe Research
    • Charter Comm (CHTR) downgraded to Underperform from Peer Perform at Wolfe Research; tgt $300
    • Commerce Bancshares (CBSH) downgraded to Equal-Weight from Overweight at Morgan Stanley; tgt lowered to $64
    • Enbridge (ENB) downgraded to Hold from Buy at Jefferies
    • Freeport-McMoRan (FCX) downgraded to Sector Perform from Sector Outperform at Scotiabank; tgt $52
    • Frontier Communications Parent (FYBR) downgraded to Peer Perform from Outperform at Wolfe Research
    • Interpublic (IPG) downgraded to Underperform from Neutral at Exane BNP Paribas
    • JPMorgan Chase (JPM) downgraded to Equal-Weight from Overweight at Morgan Stanley; tgt raised to $224
    • Procter & Gamble (PG) downgraded to Equal Weight from Overweight at Barclays; tgt $163
  • Others:
    • Adicet Bio (ACET) resumed with a Buy at Guggenheim; tgt $7
    • Autodesk (ADSK) named a Top Pick at Morgan Stanley
    • BioLife Solutions (BLFS) initiated with a Buy at H.C. Wainwright; tgt $29
    • Celldex Therapeutics (CLDX) initiated with a Neutral at Goldman; tgt $45
    • Crescent Capital BDC (CCAP) initiated with a Buy at Ladenburg Thalmann; tgt $20
    • Horizon Bancorp (HBNC) initiated with an Outperform at Hovde Group; tgt $18
    • Klaviyo (KVYO) initiated with a Buy at The Benchmark Company; tgt $42
    • Navient (NAVI) initiated with a Neutral at BofA Securities; tgt $17
    • Permian Resources (PR) initiated with a Buy at Goldman; tgt $19
    • ProKidney Corp. (PROK) initiated with a Neutral at JP Morgan
    • Skye Bioscience (SKYE) initiated with a Sector Outperform at Scotiabank; tgt $20
    • Tenax Therapeutics (TENX) initiated with an Outperform at William Blair
    • Verastem (VSTM) initiated with a Buy at Guggenheim; tgt $13